Nephron Pharmaceuticals makes quite a few products — at least for now. But what exactly are those products? The major Columbia-area employer announced Thursday evening that it decided to furlough an ...

Lexington County-based Nephron Pharmaceuticals is being sued by another drug manufacturer, which claims Nephron products are being marketed as a replacement for its own drug without FDA approval.

NRx Pharmaceuticals (NASDAQ: NRXP) announced it has re-filed its Abbreviated New Drug Application with the U.S. FDA for ...

Sharps Technology Inc., a publicly traded medical device company, has plans to acquire the first fully dedicated specialized polymer syringe manufacturing plant in North America, and has been ...

COLUMBIA — As Nephron Pharmaceuticals Corporation continues its struggle to comply with federal drug regulations, the Lexington County manufacturer has furloughed at least 70 employees without pay for ...

Sharps Technology Inc. STSS shares are trading higher Thursday after the company signed a $30 million purchase order from Nephron Pharmaceuticals. Sharps said the purchase order represents the first ...

Switzerland's Relief Therapeutics and U.S. partner NeuroRx said on Wednesday they struck deals with Bachem and Nephron Pharmaceuticals to supply and make a 50-year-old drug, aviptadil, that is in ...

Sharps Technology shares are trading higher by 60.8% during Thursday's session. The company signed a 5-year $200 million syringe sales agreement with Nephron Pharmaceuticals. Historic Summer Setup: 3 ...

Santander Corporate & Investment Banking announced that its U.S. broker-dealer, Santander US Capital Markets LLC, has entered ...